Read More Healthcare Industry News Canopy Growth Q4 misses expectations with C$221m loss, revenue down 11% Canopy Growth stock plunges as Q4 FY2025 losses widen. Revenue declines, U.S. risks rise. Will a medical cannabis pivot revive investor confidence? byPallavi MadhirajuMay 30, 2025